Personalis, Inc. financial data

Symbol
PSNL on Nasdaq
Industry
Services-Medical Laboratories
Location
6600 Dumbarton Circle, Fremont, CA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 364 % -38.4%
Debt-to-equity 62.1 % +71%
Return On Equity -63.4 % -19.5%
Return On Assets -39.1 % -0.51%
Operating Margin -113 % +33.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 53.1M shares +9.39%
Common Stock, Shares, Outstanding 53.1M shares +9.37%
Entity Public Float 90.6B USD +57977%
Weighted Average Number of Shares Outstanding, Basic 52.4M shares +9.91%
Weighted Average Number of Shares Outstanding, Diluted 52.4M shares +9.91%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 80M USD +19.2%
Cost of Revenue 57.8M USD +9.44%
Research and Development Expense 56.1M USD -15%
Costs and Expenses 171M USD -6.1%
Operating Income (Loss) -90.5M USD +20.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -81.4M USD +26.1%
Income Tax Expense (Benefit) 44K USD -36.2%
Net Income (Loss) Attributable to Parent -81.5M USD +26.1%
Earnings Per Share, Basic -1.64 USD/shares +30.5%
Earnings Per Share, Diluted -1.64 USD/shares +30.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 47.7M USD -50.9%
Accounts Receivable, after Allowance for Credit Loss, Current 12.9M USD +27.5%
Assets, Current 113M USD -29.7%
Property, Plant and Equipment, Net 52.7M USD -11.5%
Operating Lease, Right-of-Use Asset 17.2M USD -30.4%
Other Assets, Noncurrent 2.57M USD -34.7%
Assets 186M USD -25.5%
Accounts Payable, Current 9.94M USD +12.3%
Employee-related Liabilities, Current 6.31M USD -10.5%
Accrued Liabilities, Current 2.41M USD +205%
Contract with Customer, Liability, Current 4.17M USD +25.1%
Liabilities, Current 34.1M USD +19.4%
Contract with Customer, Liability, Noncurrent 341K USD
Operating Lease, Liability, Noncurrent 36.5M USD -9.43%
Other Liabilities, Noncurrent 1.06M USD -73.7%
Liabilities 73.2M USD +0.38%
Accumulated Other Comprehensive Income (Loss), Net of Tax -120K USD +61.7%
Retained Earnings (Accumulated Deficit) -494M USD -19.7%
Stockholders' Equity Attributable to Parent 112M USD -36.2%
Liabilities and Equity 186M USD -25.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -20.4M USD -29.6%
Net Cash Provided by (Used in) Financing Activities 1.13M USD
Net Cash Provided by (Used in) Investing Activities 6.3M USD -54.3%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 53.1M shares +9.37%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -13M USD -565%
Deferred Tax Assets, Valuation Allowance 145M USD +26.5%
Deferred Tax Assets, Gross 150M USD +22.7%
Operating Lease, Liability 44.4M USD -7.48%
Payments to Acquire Property, Plant, and Equipment 104K USD -97.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -81.3M USD +25.6%
Lessee, Operating Lease, Liability, to be Paid 74.6M USD -10.2%
Property, Plant and Equipment, Gross 95M USD +6.95%
Operating Lease, Liability, Current 7.86M USD +2.81%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.23M USD -13%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.06M USD -3.89%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.19M USD -1.41%
Deferred Tax Assets, Operating Loss Carryforwards 84M USD +16%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 5.7M USD +34.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.22M USD -27.5%
Operating Lease, Payments 2M USD +150%
Depreciation, Depletion and Amortization 11.4M USD +8.75%
Deferred Tax Assets, Net of Valuation Allowance 5.2M USD -33.5%
Share-based Payment Arrangement, Expense 12.2M USD -29.7%
Interest Expense 42K USD -76.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%